80 likes | 95 Views
Recent studies reported that inhibiting LAG-3 functions allows T cells to regain their cytotoxic function and affect tumor growth.
E N D
Lymphocyte Activation Gene - 3 Protein Market- GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Lymphocyte Activation Gene - 3 Protein Market – Overview Immune checkpoint receptors such as lymphocyte activation gene - 3 (LAG-3) protein are found on cell surface of effector T cells and regulatory T cells (Tregs). T cells are a type of white blood cells that eliminate unhealthy or foreign cells that enter the immune system. Function of lymphocyte activation gene - 3 protein is to control T cell response, activation, and growth. Lymphocyte activation gene - 3 turns off the immune response when a T cell is activated to eliminate a target cell. This prevents the T cells from harming healthy cells. Moreover, lymphocyte activation gene - 3 protein is associated with T cell exhaustion in which the T cells become desensitized and lose their ability to function. LAG-3 is closely associated with regulation of cytotoxic T cells and regulatory T cells, which has attracted attention of researchers and manufacturers as a therapeutic target against cancer. In cancers, lymphocyte activation gene - 3 expressing exhausted cytotoxic t cells and regulatory T cells (Tregs) are found to be gathered at tumor locations. Recent studies reported that inhibiting LAG-3 functions allows T cells to regain their cytotoxic function and affect tumor growth. There are several LAG-3 protein antibodies in the clinical trials, which are expected to further advance in clinical trials over the forecast period. © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Lymphocyte Activation Gene - 3 Protein Market Taxonomy: Lymphocyte Activation Gene - 3 Protein Market Taxonomy: By Drug Type: By Drug Type: BMS-986016 (Relatlimab) BMS-986016 (Relatlimab) ● ● IMP321 IMP321 ● ● IMP701 IMP701 ● ● MGD013 MGD013 ● ● By Cancer Type: By Cancer Type: Breast Cancer Breast Cancer ● ● Melanoma Melanoma ● ● Solid Tumors Solid Tumors ● ● Request for sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/2027 Request for sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/2027 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Lymphocyte Activation Gene - 3 Protein Market: Key Players Bristol-Myers Squibb. ● Icell Kealex Therapeutics. ● Incyte Corporation. ● MacroGenics, Inc. ● GlaxoSmithKline Plc. ● Crescendo Biologics Ltd. ● Regeneron Pharmaceuticals Inc. ● Sutro Biopharma Inc. ● View this report @ http://bit.ly/2MF4e0z © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare CLINICAL DIAGNOSTIC HEALTHCARE IT PHARMACEUTICAL MEDICAL IMAGING MEDICAL DEVICES Chemicals & Materials Speciality and Fine Chemicals Advanced Materials Bulk Chemicals Green Chemicals Polymers & Resins Food Ingredients Cosmetic Ingredients © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS KEY STATS RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES 100+ Insights Published Per Year CUSTOMIZED SOLUTIONS COUNTRY ANALYSIS 150+ CONSULT PROJECTS Consulting Projects Till Date SURVEY RESEARC H EXCEL FORECAST DATABASE 125+ COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
T o know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentm arketinsights.com THANK YOU For other queries contact: Mr. Shah (M anager - Business Development) C oherent Market Insights sales@coherentm arketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved